Omeros (OMER) Receivables (2010 - 2026)
Omeros' (OMER) quarterly Receivables came in at $12.1 million in Q1 2026, up 42.23% year-on-year from $8.5 million in Q1 2025, and up 3.92% quarter-over-quarter from $11.7 million in Q4 2025.
Omeros (OMER) Receivables (2010 - 2026) Analysis & Trends
Omeros has disclosed Receivables across 17 years of filings, most recently posting $12.1 million for Q1 2026.
- Receivables for Q1 2026 came in at $12.1 million, up 42.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.1 million (up 42.23% YoY), and the FY2025 annual result was $11.7 million, up 36.65% from the prior year.
- Receivables came in at $12.1 million for Q1 2026 at Omeros, up from $11.7 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $226.2 million in Q4 2022 to a low of $7.0 million in Q1 2023.
- The 5-year median for Receivables is $11.7 million (2025), against an average of $23.9 million.
- Across the five-year window, Receivables surged 8324.1% in 2022 and plunged 95.81% in 2023, its largest moves.
- Omeros' Receivables stood at $226.2 million in 2022, then slumped by 95.81% to $9.5 million in 2023, then decreased by 9.82% to $8.5 million in 2024, then soared by 36.65% to $11.7 million in 2025, then climbed by 3.92% to $12.1 million in 2026.
- The last three Receivables figures came in at $12.1 million (Q1 2026), $11.7 million (Q4 2025), and $7.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | 12.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.12 Mn |
| Dec 31, 2025 | 11.67 Mn |
| Sep 30, 2025 | 7.77 Mn |
| Jun 30, 2025 | 7.34 Mn |
| Mar 31, 2025 | 8.52 Mn |
| Dec 31, 2024 | 8.54 Mn |
| Sep 30, 2024 | 12.49 Mn |
| Jun 30, 2024 | 14.89 Mn |
| Mar 31, 2024 | 8.30 Mn |
| Dec 31, 2023 | 9.47 Mn |
| Sep 30, 2023 | 13.54 Mn |
| Jun 30, 2023 | 11.32 Mn |
| Mar 31, 2023 | 6.99 Mn |
| Dec 31, 2022 | 226.19 Mn |
| Sep 30, 2022 | 14.64 Mn |
| Jun 30, 2022 | 15.31 Mn |
| Mar 31, 2022 | 16.66 Mn |
| Dec 31, 2021 | 2.69 Mn |
| Sep 30, 2021 | 33.90 Mn |
| Jun 30, 2021 | 32.26 Mn |